Marketresearchnews

Tuesday, 9 April 2019

Dental Bone Graft Substitutes Market 2019 Share, Trend, Segmentation and Forecast to 2023

Global dental bone graft substitutes market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 461.3 million in 2017 and is projected to grow at a CAGR of 9.4% over the forecast period.

The factors such as increasing incidence of oral diseases namely, dental caries and periodontal diseases and growing medical tourism in developing countries are expected to propel the growth of the market. However, lack of proper reimbursement and stringent regulations hamper the market growth over the forecast period.

Global Dental Bone Graft Substitutes, by Key Players

Biohorizons Iph, Inc. (US)
Geistlich Pharma AG (Switzerland)
Dentsply Sirona (US)
Institut Straumann AG (Switzerland)
Medtronic Plc (US)
Zimmer Biomet Dental (US)
Dentium (South Korea)
LifeNet Health (US)
Orthogen, LLC (US)

Segmentation

The global dental bone graft substitutes market has been segmented into type, application, and end user.

Based on type, dental bone graft substitutes market is segmented into allograft, xenograft, alloplast, and others.

Based on application, dental bone graft substitutes market is segmented into ridge augmentation, sinus lift, socket preservation, periodontal defect, and implant bone regeneration.

Based on end user, dental bone graft substitutes market is segmented into dental clinics, hospitals, and others. The dental clinics segment is expected to account for the largest share segment of the market in 2017.

The dental bone graft substitutes market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The dental bone graft substitutes market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada.

The European dental bone graft substitutes market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The dental bone graft substitutes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The dental bone graft substitutes market in the Middle East & Africa segmented into the Middle East and Africa.

Regional Market Summary

Geographically, Europe is anticipated to dominate the global dental bone graft substitutes market owing to a well-established player and increasing incidence of oral diseases namely, dental caries and periodontal diseases.

The Americas is expected to hold the second largest position in the global dental bone graft substitutes market. The market growth in this region is attributed to increasing incidence of oral diseases such as dental caries and periodontal diseases and growing ageing population.

The dental bone graft substitutes market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region. The market growth in this region is attributed to growing medical tourism in developing countries.

The Middle East & Africa has the least share of the dental bone graft substitutes market.

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/dental-bone-graft-substitutes-market-7321

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Monday, 8 April 2019

Surgical Retractors Market Segmentation Detailed Study with Forecast Up To 2018

Retractors are surgical instrument which are used to separate the edges of the wound or surgical incision.

The factors such as increasing number of surgical procedures is the major driving factor for the market. Beside this technological advances and improved surgical treatment with increased success rate has provided fuel for the growth of the market. Cost of surgery and surgical products may restrain the growth of the market.

According to WHO, in 2015, more than 35% of the total global population were suffering from major or minor cardiovascular complication and in 2014, globally 39% of adults aged 18 years and over were overweight whereas 13% were obese.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7019

Global Surgical Retractors Market is expected to grow significantly over the forecast period. The market held a market value of USD 1,103 million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period.

Key players:

Terumo Corporation, Henry Schein, INC., Johnson & Johnson, Medtronic, Becton, Dickinson and Company, Stryker Corporation, Globus Medical, INC., B. Braun Melsungen AG, Teleflex Incorporated, Integra Lifesciences Holdings Corporation, The Cooper Companies, INC., RTI Surgical, INC., Arthrex, Inc., Invuity, Inc., Medline Industries, Inc. are some of the prominent players in the global surgical retractors market.

Segmentation:

The European Surgical Retractors Market has been segmented into Western Europe and Eastern Europe. The Western Europe surgical retractors market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Surgical Retractors Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical retractors market in the Middle East & Africa has been segmented into the Middle East and Africa.

The Global Surgical Retractors Market has been segmented into product type, design, product usage, application, and end user. By product type, the market has been segmented into hand retractors, self-retaining retractors, table-mounted retractors, wire retractors, and accessories.Based on design, the market has been segmented into fixed or flat frame retractors, angled or curved frame retractors, and blade or elevated-tipped retractors. Based on product usage, the market has been segmented into tissue handling and dissection and fluid swabbing.

Based on application, the market has been segmented into obstetric & gynaecological, urological, abdominal, cardiothoracic, orthopaedic, head, neck, and spinal, aesthetic surgical, and others. The market, by end user, has been segmented into hospitals and surgical centres, ambulatory care centres, and others.The Global Surgical Retractors Market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical retractors market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global surgical retractors market owing to the high domestic income, and presence of major market players. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion.

Europe is expected to hold the second largest position in the global surgical retractors market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The Surgical Retractors Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing patient population and growing focus of major market players in the region.

The Middle East & Africa has the lowest share of the global surgical retractors market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/surgical-retractors-market-7019

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Current and forthcoming Optical Imaging Market size in terms of volume and value 2018

The global optical imaging market is expected to be of value USD 1.92 Billion in 2023 and to grow at a depict 10% CAGR during the forecast period. Optical imaging is a non-invasive technique in which light is used to interrogate cellular and molecular function in the living body by exploiting the special properties of photons. This market is mainly driven by rising demand for non-invasive procedures, harmful effects of radiation-based imaging, increase in research and development activities in the life sciences sector, and increasing application of optical imaging techniques in drug discovery processes and preclinical research, Moreover factors such as rising geriatric population which leads to increase in cardiovascular, neurological and ophthalmic disorders is also fueling the growth of this market.

However, factors such as stringent regulatory approval procedures high costs of instruments, scarcity of skilled operators, and insufficient reimbursements policies for optical imaging procedures restrict market growth.

Key players

Jude Medical, Inc., Carl Zeiss Meditec AG, Bioptigen, Inc., Canon Inc, Heidelberg Engineering, Inc., Topcon Corporation, Perkinelmer, Inc., Koninklijke Philips N.V., Agfa-Gevaert N.V.

Segmentation

The global optical imaging market is segmented on the basis of products, techniques, therapeutic area, application, and end-user. Considering the type of product, the market is segmented into imaging systems, software, lenses, illumination systems, cameras and others. Imaging systems are further segmented into optical imaging systems and spectral imaging systems. On the basis of technique, the market is segmented into Optical Coherence Tomography (OCT), photoacoustic imaging, diffused optical tomography, hyperspectral imaging, near-infrared spectroscopy, and super-resolution microscopy.

On a therapeutic area basis, it is segmented into neurology, oncology, ophthalmology, dentistry, cardiology, dermatology, and others. On account of application, the market is segmented into pre-clinical and clinical research, pathological imaging and intraoperative imaging. According to the end-user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Regional Market Summary

In terms of geography, Americas dominates the market for optical imaging owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders about rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems and presence of pharmaceutical giants key players also propel the market growth in this region. For instance, according to National cancer institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S. Thus, this huge patient pool is going to boost up the market growth during the forecast period.

Europe is the second largest market and holds a healthy share in the global optical imaging market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of optical imaging over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth.

Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the department of neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period. Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in optical imaging market in future.

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/optical-imaging-market-6172

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Surgical Equipment Market to Observe Strong Development by 2018

Market Scenario

Surgical equipment have wide applications in distinctive surgical techniques, for example, neurosurgery, plastic and reconstructive surgeries, wound closure, urology, obstetrics and gynaecology, thoracic surgery, micro-vascular, cardiovascular, orthopaedic surgery, laparoscopy and others. The market is driven by increasing number of surgeries, & hospitals, increasing prevalence of different diseases and increasing geriatric population have boosted the market growth. Moreover, technological advancement, increasing number of ambulatory services and government initiatives have a synergistic effect on the market. However, high cost of the devices, shortage of skilled labour and strict regulatory policies are the major restraints for the market

The global surgical equipment market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, obesity, skin diseases, increasing number of surgeries in ambulatory surgical centers and hospitals, and rising geriatric population. Additionally, the growth of the medical device market, increasing number of surgical centers, and government initiatives have a synergistic effect on the market. However, the growth of the market is restrained by various factors such as high cost of surgical devices and strict regulatory policies for various regulatory authorities.

The global surgical equipment market is expected to grow at a CAGR of 6.2% during the forecast period.

Latest Industry News

Surgical services at the Georgetown Public Hospital have received a donation of medical equipment and supplies from the government of China. 28 DEC 2018
AppOrtho is utilizing the High Country’s first robot-assisted surgery system to aid with knee replacement surgeries. 3 JAN 2019

Key Players

The key players in the global surgical equipment market include B. Braun Melsungen AG (Germany), CONMED Corporation (USA), COVIDIEN (USA), Erbe Elektromedizin GmbH (Germany), Ethicon USA, LLC. (USA), Integra LifeSciences Corporation (USA), KARL STORZ & Co. (USA), KLS Martin (Germany) MEDICON (USA), Smith & Nephew (UK), and Stryker Corporation (USA).

Segmentation

The global surgical equipment market is divided into product type, application, and end-user.

On the basis of product type, the market is segmented into surgical sutures and staplers, handheld instruments, electrosurgical devices, electrosurgical generators, monitoring devices, and others. Surgical sutures and staplers are further segmented into absorbable and non-absorbable sutures. Handheld instruments are sub-segmented into forceps, sutures, visual scope, and others. Electrosurgical devices are further categorized into electrosurgical instruments such as HET bipolar system, electrosurgical pencils, smoke evacuation system, electrosurgical generators, and others.

On the basis of application, the market is segmented into neurosurgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others.

On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, and others.

Regional Analysis

Americas holds the largest share of the surgical equipment market. The growth of the medical device sector, increasing emphasis on quality care, and the availability of technologically-advanced surgical devices are the major drivers for the growth of the market. North America holds the largest share, with the U.S. being the largest contributor to the growth of the market. In the U.S., the presence of key players in the medical device industry and extensive use of surgical devices drive the market. South America also exhibits tremendous growth opportunities with an increase in the demand for surgical devices. The Agency for Healthcare Research and Quality reported that nearly 11 million and 10 million invasive and therapeutic surgeries were carried out in ambulatory and inpatient settings, respectively, in the U.S. in 2014.

Europe, Germany, the U.K., and France are the major contributors to the growth of the market. The increasing number of market players manufacturing surgical equipment, growing government support, and increase in outpatient surgeries drive the market in the European nations. Additionally, increasing healthcare spending by European nations such as the U.K. and Germany also contributes to the growth of the market.

The Asia Pacific, surgical equipment market, is driven by the huge demand for surgical devices and instruments, increasing awareness about quality care in hospitals and surgical centers, and the ever-increasing prevalence of chronic diseases such as cardiovascular diseases. India and Australia exhibit the fastest growth in the market owing to the availability of qualified and skilled medical professionals and growing healthcare expenditure.

In the Middle East and Africa, the market growth is attributed to the increasing availability of specialty care services in countries such as the United Arab Emirates and Saudi Arabia. Africa exhibits a steady growth with the demand for primary care services in the region.

Browse Complete 130 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/surgical-equipment-market-556

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Leukemia Therapeutics Market 2018 Analysis, Opportunities and Forecast to 2023

Leukemia is blood cancer which most commonly in adults and children. Acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia are the major types of the leukemia. Leukemia therapeutics are used in treating the leukemia.

The globalleukemia therapeutics anticipated to have held a market value of USD 10.7 billion in the year 2017 and is expected to grow at a CAGR of 5.3% during the forecast period.

Segmentation

The global leukemia therapeutics market has been segmented into type, applications, and region.

Based on type, leukemia therapeutics market is segmented into chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant. The chemotherapy segment is expected to account for the largest share segment of the market in 2017. Chemotherapy segment further sub segmented into alkylating agents, antimetabolites, antitumor antibiotics, and others.

Based on applications, leukemia therapeutics market is segmented into acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, and others. The acute lymphocytic leukemia segment is expected to account for the largest share segment of the market in 2017.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global leukemia therapeutics market owing to a well-established player, innovative therapies to drive the market for leukemia, increase prevalence of leukemia, and increasing older population.

Europe is expected to hold the second largest position in the global leukemia therapeutics market. The market growth in this region is attributed to increase prevalence of leukemia.

The leukemia therapeutics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.

The Middle East & Africa has the least share of the leukemia therapeutics market.

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/leukemia-therapeutics-market-7425

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiac Valve Market - Granular Market Report and Review, 2018

Market scenario

The global cardiac valve market is expected to grow at a CAGR of 11.5% during the forecasted period.

Increasing number of people with cardiovascular diseases and increasing number of cardiac surgery have stimulated the growth of the market. Additionally, increasing incident of diabetes and obesity, adoption of deskbound lifestyle rising geriatric population, and excessive use of tobacco and alcohol projected to propel the growth of the market.

Cardiac valve or heart valve allows blood to flow in only one direction through the heart. Human heart consists of four valves. These valves open and closes compulsory on differential blood pressure on each side.

On the other hand, high cost of treatment methods may hamper the growth of the global cardiac valve market over the forecast period.

Segmentation

The global cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.

On the basis of types, the market is segmented into trans-catheter heart valve, tissue heart valve, mechanical heart valve, and others.

On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.

On the basis of treatments, it is segmented into valve replacement, valve repair, and others.

On the basis of end users the market is segmented into cardiac research institute, hospital & clinics, and others.

Key players

Medtronic,
Edwards Lifesciences Corporation (U.S.),
Boston Scientific Corporation (U.S.),
Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.),
LivaNova PLC (U.K.),
Symetis SA (Switzerland),
Jenavalve Technology, Inc. (Germany),
CryoLife, Inc. (U.S.),
TTK HealthCare (India),
Colibri Heart Valve, LLC (U.S.),
Lepu Medical Technology Co., Ltd. (China),
Braile Biomédica (Brazil)

Regional analysis

The Americas mainly include North America and South America of which North America dominates the market owing to the presence of huge number of patient with cardiac diseases, increasing geriatric population, and increasing healthcare expenditure.

In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of cardiovascular diseases drive the growth of the market in this region.

Europe is the second highest revenue generating region in the cardiac valve market. Europe is mainly consist of Eastern Europe and Western Europe. More developed countries of Western Europe such as Germany, France, and the UK are holding the major market share, whereas the East European countries are also growing at a significant rate. Moreover, owing to developing healthcare infrastructure and increasing healthcare expenditure will boost the market growth in this region.

The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiac-valve-market-560

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Friday, 5 April 2019

Breast Biopsy Market 2018 Analysis, Opportunities and Forecast to 2023

The prevalence of breast cancer has led to an increased level of reliance on breast biopsy procedures. Improved screening campaigns are also increasing the need for breast biopsy procedures. Furthermore, the rise in the awareness regarding cancer is anticipated to further motivate the expansion of the breast biopsy market in the forecast period.

Increased cancer detection rates globally have contributed to a rise in biopsy procedures. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is projected to develop at a favorable CAGR rate in the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6288

Competitive Landscape

Significant reductions in administrative costs are inducing further expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market players. The development of a robust value chain is further motivating the development of the market. The strategic goals intended for the market are reinforced due to favorable product differentiation carried out by market competitors. The growth of the market is moving in a favorable direction due to new product launches or rising gross revenue of the players in the market. Increased adaptability of market players to new market trends and customers inclinations are lifting the growth curve of the market and will continue do so in the forecast period. The successful implementation of strategies is expected to motivate the market in the coming years.

The main players in the breast biopsy market globally are C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Cook Medical Incorporated, Leica Biosystems, Encapsule Medical Devices LLC., Johnson & Johnson, Intact Medical Corporation, Becton, Dickinson and Company, Conceptus INC, Hologic Inc., Galini SRL, Karl Storz GmbH & Co. Kg, GE Healthcare.

Segmentation

The breast biopsy market has been carried out on the basis of guidance technology, technique type, product, and end-user. Based on product, the breast biopsy market has been segmented into biopsy tables, guidance systems, biopsy needles, biopsy wires, and others. The segmentation on the basis of technique type, the market is segmented into core needle biopsy, biopsy markers, fine needle aspiration biopsy, surgical biopsy, MRI-guided core needle biopsy, wire localization, and sentinel node biopsy. Additionally, the core needle biopsy segment is segmented into vacuum-assisted biopsy, ultrasound-guided core biopsy, stereotactic core needle biopsy, and freehand core-needle biopsy. The surgical biopsy is divided into excisional biopsy and incisional biopsy. Based on guidance technology, the breast biopsy market is segmented into mammography-guided magnetic resonance, CT-guided biopsy, ultrasound-guided, and other image-guided breast biopsy (thermography and PET). The end-user based segmentation of the market consists of ambulatory surgical centers, hospitals, diagnostic centers, among others. The regions that are a part of the breast biopsy market are Europe, Asia Pacific, Americas, and the Middle East and Africa.

Detailed Regional Analysis

The regional analysis of the breast biopsy market observes that the North American region is projected to account for the principal market share owing to the early implementation of sophisticated medical technologies and constant development by companies working in cancer diagnostics. The breast biopsy market is mainly focused on the North American and European regions, which is expected to account for more than 50% of the market portion. The European market is estimated to hold the next biggest market share as breast cancer is found to be most common in countries such as the UK and Belgium. The market share in the Asia Pacific region is also estimated to experience growth in the near future due to access to optimal treatment facilities, better adoption rate, growing demand for advanced technology, growing government initiatives, and rising healthcare costs. The market in the Middle Eastern and African region is projected to be responsible for the smallest share of the breast biopsy market owing to deficiency of technical knowledge, an underdeveloped healthcare sector, and meager medical facilities.

Browse Complete 100 Pages Premium Research Report Enabled with 90 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com